bevespi aerosphere
astrazeneca ab - glycopyrronium, formoterol fumarate dihydrate - boala pulmonară, obstructivă cronică - formoterol și bromura de glicopironiu - bevespi aerosphere este indicat în tratamentul bronhodilatator de întreținere pentru ameliorarea simptomelor la pacienții adulți cu boală pulmonară obstructivă cronică (bpoc).
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - boala pulmonară, obstructivă cronică - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - boala pulmonară, obstructivă cronică - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
bevespi aerosphere 7,2 micrograme/5 micrograme
astrazeneca dunkerque production - franta - combinatii (glicopironium+formoterolum) - susp. de inhalat presurizata - 7,2micrograme/5micrograme - adrenergice inhalante adrenergice inhalante
riltrava aerosphere 5 micrograme/7,2 micrograme/160 micrograme
astrazeneca dunkerque production - franta - formoterolum+glicopironiu+budesonidum - susp. de inhalat presurizata - 5 µg/7,2 µg/160 µg - adrenergice inhalante adrenergice in combinatie cu anticolinergice
trixeo aerosphere 5 micrograme/7,2 micrograme/160 micrograme
astrazeneca dunkerque production - franta - formoterolum+glicopironiu+budesonidum - susp. de inhalat presurizata - 5µg/7,2µg/160µg - adrenergice inhalante adrenergice in combinatie cu anticolinergice
fluorouracil-bp 50 mg/ml soluţie injectabilă/perfuzabilă
sc balkan pharmaceuticals srl - fluorouracilum - soluţie injectabilă/perfuzabilă - 50 mg/ml
fluorouracil-bp 50 mg/ml soluţie injectabilă/perfuzabilă
sc balkan pharmaceuticals srl - fluorouracilum - soluţie injectabilă/perfuzabilă - 50 mg/ml
fluorouracil accord 50 mg/ml
accord healthcare limited - marea britanie - fluorouracilum - sol. inj. sau perf. - 50mg/ml - antimetaboliti analogi ai bazelor pirimidinice
fluorouracil accord 50 mg/ml
accord healthcare polska sp. z.o.o. - polonia - fluorouracilum - sol. inj. sau perf. - 50mg/ml - antimetaboliti analogi ai bazelor pirimidinice